Study Finds Handheld Far UV-C Devices Effectively Reduce Surface Pathogens in a Healthcare Setting
Retrieved on:
Monday, April 29, 2024
Technology, Health Technology, Research, Medical Devices, Infectious Diseases, Hospitals, Urban Planning, Clinical Trials, Public Transport, Transportation, Lodging, Health, Building Systems, Travel, Practice Management, Managed Care, General Health, Science, COVID-19, Transport, Other Technology, Other Construction & Property, Construction & Property, Other Health, Infection, The International, System, Partner, Filtration, Bone marrow, Safety, Bacteria, Disinfectant, University, Patient, Spore, Virus, Fungus, MD Anderson Cancer Center, Ultraviolet, Death, ICHS, Vaccine
In U.S. healthcare facilities alone, 1.7 million patients contract HAIs annually and HAIs cause 99,000 deaths every year .
Key Points:
- In U.S. healthcare facilities alone, 1.7 million patients contract HAIs annually and HAIs cause 99,000 deaths every year .
- Surface pathogens can persist for days to months and studies show that 50% of surfaces in healthcare environments do not receive adequate levels of disinfection during manual chemical cleaning.
- This study continued to validate the highly effective and rapid reduction of harmful pathogens on most high touch surfaces.
- “This study provides further real-world data on the efficacy of handheld Filtered Far UV-C devices to reduce surface pathogens which we hope could ultimately improve patient care and tackle the tremendous expenses healthcare institutions face in fighting HAIs,” said Jennifer Rosen, co-founder of Freestyle Partners, LLC.